INS and cancer: There is evidence that plasma levels of insulin or the C-peptide, which is the peptide that is cleaved from insulin during its biosynthesis, are associated with colon [155–158], endometrial [159], breast [158, 160], prostate [161] and pancreatic [162] cancers.